HEADER TRANSFERASE 08-JUL-02 1M52 TITLE CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH PD173955 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (RESIDUES 232-503); COMPND 5 SYNONYM: P150, C-ABL; COMPND 6 EC: 2.7.1.112; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PFASTBAC KEYWDS KINASE, KINASE INHIBITOR, PD173955, ACTIVATION LOOP, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR B.NAGAR,W.BORNMANN,P.PELLICENA,T.SCHINDLER,D.VEACH,W.T.MILLER, AUTHOR 2 B.CLARKSON,J.KURIYAN REVDAT 3 14-FEB-24 1M52 1 REMARK SEQADV REVDAT 2 24-FEB-09 1M52 1 VERSN REVDAT 1 18-SEP-02 1M52 0 JRNL AUTH B.NAGAR,W.BORNMANN,P.PELLICENA,T.SCHINDLER,D.VEACH, JRNL AUTH 2 W.T.MILLER,B.CLARKSON,J.KURIYAN JRNL TITL CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF C-ABL IN COMPLEX JRNL TITL 2 WITH THE SMALL MOLECULE INHIBITORS PD173955 AND IMATINIB JRNL TITL 3 (STI-571) JRNL REF CANCER RES. V. 62 4236 2002 JRNL REFN ISSN 0008-5472 JRNL PMID 12154025 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.25 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 24847 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2469 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3426 REMARK 3 BIN R VALUE (WORKING SET) : 0.2620 REMARK 3 BIN FREE R VALUE : 0.3170 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 397 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4422 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 116 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.33000 REMARK 3 B22 (A**2) : -3.55000 REMARK 3 B33 (A**2) : -3.78000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.39 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.750 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.320 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.820 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.930 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.390 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 32.89 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : P17.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : P17.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1M52 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUL-02. REMARK 100 THE DEPOSITION ID IS D_1000016607. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-SEP-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25520 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 85.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.36000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FPU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 0.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 20000, MES, ISOPROPANOL, PH 6.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 57.92400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 62.85400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 57.92400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 62.85400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 223 REMARK 465 ALA A 224 REMARK 465 MET A 225 REMARK 465 ASP A 226 REMARK 465 PRO A 227 REMARK 465 SER A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 ASN A 231 REMARK 465 SER A 503 REMARK 465 ASP A 504 REMARK 465 GLU A 505 REMARK 465 VAL A 506 REMARK 465 GLU A 507 REMARK 465 LYS A 508 REMARK 465 GLU A 509 REMARK 465 LEU A 510 REMARK 465 GLY A 511 REMARK 465 LYS A 512 REMARK 465 ARG A 513 REMARK 465 GLY A 514 REMARK 465 THR A 515 REMARK 465 GLY B 223 REMARK 465 ALA B 224 REMARK 465 MET B 225 REMARK 465 ASP B 226 REMARK 465 PRO B 227 REMARK 465 SER B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 ASN B 231 REMARK 465 ASP B 504 REMARK 465 GLU B 505 REMARK 465 VAL B 506 REMARK 465 GLU B 507 REMARK 465 LYS B 508 REMARK 465 GLU B 509 REMARK 465 LEU B 510 REMARK 465 GLY B 511 REMARK 465 LYS B 512 REMARK 465 ARG B 513 REMARK 465 GLY B 514 REMARK 465 THR B 515 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 245 -83.49 -126.22 REMARK 500 LYS A 262 -64.84 -22.09 REMARK 500 SER A 265 29.59 46.01 REMARK 500 CYS A 330 159.80 -48.23 REMARK 500 THR A 389 -69.52 -133.25 REMARK 500 HIS A 396 107.17 -52.54 REMARK 500 ALA A 397 126.81 -30.36 REMARK 500 LYS A 454 8.49 -66.04 REMARK 500 LYS B 245 -119.32 -108.74 REMARK 500 LYS B 262 -60.74 -25.11 REMARK 500 LYS B 274 -69.80 -26.50 REMARK 500 ASP B 276 49.63 16.00 REMARK 500 THR B 277 -162.14 -60.72 REMARK 500 THR B 389 -69.18 -127.24 REMARK 500 TYR B 440 59.84 35.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES B 117 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES B 118 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P17 A 119 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P17 B 120 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IEP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571 DBREF 1M52 A 229 515 UNP P00520 ABL1_MOUSE 229 515 DBREF 1M52 B 229 515 UNP P00520 ABL1_MOUSE 229 515 SEQADV 1M52 GLY A 223 UNP P00520 CLONING ARTIFACT SEQADV 1M52 ALA A 224 UNP P00520 CLONING ARTIFACT SEQADV 1M52 MET A 225 UNP P00520 CLONING ARTIFACT SEQADV 1M52 ASP A 226 UNP P00520 CLONING ARTIFACT SEQADV 1M52 PRO A 227 UNP P00520 CLONING ARTIFACT SEQADV 1M52 SER A 228 UNP P00520 CLONING ARTIFACT SEQADV 1M52 GLY B 223 UNP P00520 CLONING ARTIFACT SEQADV 1M52 ALA B 224 UNP P00520 CLONING ARTIFACT SEQADV 1M52 MET B 225 UNP P00520 CLONING ARTIFACT SEQADV 1M52 ASP B 226 UNP P00520 CLONING ARTIFACT SEQADV 1M52 PRO B 227 UNP P00520 CLONING ARTIFACT SEQADV 1M52 SER B 228 UNP P00520 CLONING ARTIFACT SEQRES 1 A 293 GLY ALA MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 A 293 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 A 293 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 A 293 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 A 293 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 A 293 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 A 293 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 A 293 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 A 293 LEU ARG GLU CYS ASN ARG GLN GLU VAL SER ALA VAL VAL SEQRES 10 A 293 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 A 293 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 A 293 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 A 293 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 A 293 THR TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 A 293 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 A 293 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 A 293 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 A 293 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 A 293 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 A 293 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 A 293 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 A 293 MET PHE GLN GLU SER SER ILE SER ASP GLU VAL GLU LYS SEQRES 23 A 293 GLU LEU GLY LYS ARG GLY THR SEQRES 1 B 293 GLY ALA MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 B 293 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 B 293 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 B 293 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 B 293 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 B 293 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 B 293 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 B 293 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 B 293 LEU ARG GLU CYS ASN ARG GLN GLU VAL SER ALA VAL VAL SEQRES 10 B 293 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 B 293 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 B 293 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 B 293 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 B 293 THR TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 B 293 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 B 293 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 B 293 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 B 293 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 B 293 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 B 293 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 B 293 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 B 293 MET PHE GLN GLU SER SER ILE SER ASP GLU VAL GLU LYS SEQRES 23 B 293 GLU LEU GLY LYS ARG GLY THR HET P17 A 119 29 HET MES B 117 12 HET MES B 118 12 HET P17 B 120 29 HETNAM P17 6-(2,6-DICHLORO-PHENYL)-8-METHYL-2-(3-METHYLSULFANYL- HETNAM 2 P17 PHENYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETSYN P17 PD173955 FORMUL 3 P17 2(C21 H16 CL2 N4 O S) FORMUL 4 MES 2(C6 H13 N O4 S) FORMUL 7 HOH *116(H2 O) HELIX 1 1 GLY A 249 GLN A 252 5 4 HELIX 2 2 LYS A 263 SER A 265 5 3 HELIX 3 3 GLU A 279 LYS A 291 1 13 HELIX 4 4 ASN A 322 CYS A 330 1 9 HELIX 5 5 SER A 336 ASN A 358 1 23 HELIX 6 6 ALA A 365 ARG A 367 5 3 HELIX 7 7 GLU A 373 HIS A 375 5 3 HELIX 8 8 PRO A 402 THR A 406 5 5 HELIX 9 9 ALA A 407 ASN A 414 1 8 HELIX 10 10 SER A 417 THR A 434 1 18 HELIX 11 11 ASP A 444 LYS A 454 1 11 HELIX 12 12 PRO A 465 TRP A 476 1 12 HELIX 13 13 ASN A 479 ARG A 483 5 5 HELIX 14 14 SER A 485 SER A 501 1 17 HELIX 15 15 GLU B 238 THR B 240 5 3 HELIX 16 16 GLY B 249 GLN B 252 5 4 HELIX 17 17 LYS B 263 SER B 265 5 3 HELIX 18 18 GLU B 279 ILE B 293 1 15 HELIX 19 19 ASN B 322 CYS B 330 1 9 HELIX 20 20 SER B 336 LYS B 357 1 22 HELIX 21 21 ALA B 365 ARG B 367 5 3 HELIX 22 22 GLU B 373 HIS B 375 5 3 HELIX 23 23 PRO B 402 THR B 406 5 5 HELIX 24 24 ALA B 407 ASN B 414 1 8 HELIX 25 25 SER B 417 THR B 434 1 18 HELIX 26 26 ASP B 444 SER B 446 5 3 HELIX 27 27 GLN B 447 LYS B 454 1 8 HELIX 28 28 PRO B 465 TRP B 476 1 12 HELIX 29 29 ASN B 479 ARG B 483 5 5 HELIX 30 30 SER B 485 SER B 503 1 19 SHEET 1 A 5 ILE A 242 LYS A 247 0 SHEET 2 A 5 VAL A 256 TRP A 261 -1 O GLU A 258 N HIS A 246 SHEET 3 A 5 LEU A 266 THR A 272 -1 O VAL A 270 N TYR A 257 SHEET 4 A 5 TYR A 312 GLU A 316 -1 O THR A 315 N ALA A 269 SHEET 5 A 5 LEU A 301 CYS A 305 -1 N GLY A 303 O ILE A 314 SHEET 1 B 2 PHE A 359 HIS A 361 0 SHEET 2 B 2 LEU A 384 ARG A 386 -1 O SER A 385 N ILE A 360 SHEET 1 C 2 CYS A 369 GLY A 372 0 SHEET 2 C 2 LEU A 376 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 D 2 TYR A 393 THR A 394 0 SHEET 2 D 2 LYS A 415 PHE A 416 -1 O PHE A 416 N TYR A 393 SHEET 1 E 5 ILE B 242 LYS B 247 0 SHEET 2 E 5 VAL B 256 TRP B 261 -1 O VAL B 260 N THR B 243 SHEET 3 E 5 LEU B 266 LEU B 273 -1 O VAL B 268 N GLY B 259 SHEET 4 E 5 PHE B 311 GLU B 316 -1 O THR B 315 N ALA B 269 SHEET 5 E 5 LEU B 301 CYS B 305 -1 N GLY B 303 O ILE B 314 SHEET 1 F 2 PHE B 359 HIS B 361 0 SHEET 2 F 2 LEU B 384 ARG B 386 -1 O SER B 385 N ILE B 360 SHEET 1 G 2 CYS B 369 VAL B 371 0 SHEET 2 G 2 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 H 2 TYR B 393 THR B 394 0 SHEET 2 H 2 LYS B 415 PHE B 416 -1 O PHE B 416 N TYR B 393 CISPEP 1 PRO A 309 PRO A 310 0 -0.24 CISPEP 2 PRO B 309 PRO B 310 0 0.02 SITE 1 AC1 7 ARG A 367 PRO A 402 ILE A 403 LYS A 404 SITE 2 AC1 7 TRP A 405 LEU A 445 GLU B 466 SITE 1 AC2 5 PRO B 402 ILE B 403 LYS B 404 TRP B 405 SITE 2 AC2 5 LEU B 445 SITE 1 AC3 15 GLY A 249 TYR A 253 VAL A 256 ALA A 269 SITE 2 AC3 15 LYS A 271 GLU A 286 MET A 290 ILE A 313 SITE 3 AC3 15 THR A 315 GLU A 316 MET A 318 GLY A 321 SITE 4 AC3 15 ALA A 380 ASP A 381 PHE A 382 SITE 1 AC4 16 TYR B 253 VAL B 256 ALA B 269 LYS B 271 SITE 2 AC4 16 GLU B 286 MET B 290 ILE B 313 THR B 315 SITE 3 AC4 16 GLU B 316 MET B 318 THR B 319 GLY B 321 SITE 4 AC4 16 LEU B 370 ALA B 380 ASP B 381 PHE B 382 CRYST1 115.848 125.708 56.718 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008632 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007955 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017631 0.00000